Eventide Asset Management - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 69 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2015$253,000
-22.4%
16,000
-46.7%
0.01%
-44.0%
Q1 2015$326,000
+3.2%
30,0000.0%0.02%
-26.5%
Q4 2014$316,000
-18.3%
30,000
-25.7%
0.03%
-37.0%
Q3 2014$387,000
-17.1%
40,4000.0%0.05%
-15.6%
Q2 2014$467,000
+15.6%
40,4000.0%0.06%
+1.6%
Q1 2014$404,000
-23.2%
40,4000.0%0.06%
-61.1%
Q4 2013$526,00040,4000.16%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders